PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer Article

ESI Most Cited Paper Industry Collaboration

cited authors

  • Patel, Jyoti D.; Socinski, Mark A.; Garon, Edward B.; Reynolds, Craig H.; Spigel, David R.; Olsen, Mark R.; Hermann, Robert C.; Jotte, Robert M.; Beck, Thaddeus; Richards, Donald A.; Guba, Susan C.; Liu, Jingyi; Frimodt-Moller, Bente; John, William J.; Obasaju, Coleman K.; Pennella, Eduardo J.; Bonomi, Philip; Govindan, Ramaswamy

authors

Publication Date

  • December 1, 2013

webpage

published in

category

start page

  • 4349

end page

  • U77

volume

  • 31

issue

  • 34